Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alireza Atri

Showing results (21-30 of 143) with videos related to

Pageof 15
Sort By:
Alzheimer Disease and Associated Disorders|June 27, 2008
Long-term course and effectiveness of combination therapy in Alzheimer diseaseAlireza Atri, Lynn W Shaughnessy, Joseph J Locascio, et al.
BMC Geriatrics|September 25, 2016
In the Information Age, do dementia caregivers get the information they need? Semi-structured interviews to determine informal caregivers' education needs, barriers, and preferencesKendra Peterson, Howard Hahn, Amber J Lee, et al.
Alzheimer'S Research & Therapy|May 11, 2021
Aducanumab produced a clinically meaningful benefit in association with amyloid loweringJeffrey Cummings, Paul Aisen, Cynthia Lemere, et al.
Alzheimer'S Research & Therapy|January 23, 2013
Memantine in patients with Alzheimer's disease receiving donepezil: new analyses of efficacy and safety for combination therapyAlireza Atri, José L Molinuevo, Ole Lemming, et al.
Journal of the International Neuropsychological Society : JINS|October 9, 2012
Neuropsychological test performance and cognitive reserve in healthy aging and the Alzheimer's disease spectrum: a theoretically driven factor analysisMeghan B Mitchell, Lynn W Shaughnessy, Steven D Shirk, et al.
Behavioral Neuroscience|June 14, 2003
Scopolamine impairs human recognition memory: data and modelingSeth J Sherman, Alireza Atri, Michael E Hasselmo, et al.
Brain : a Journal of Neurology|June 6, 2023
Amyloid-related imaging abnormalities (ARIA): radiological, biological and clinical characteristicsHarald Hampel, Aya Elhage, Min Cho, et al.
The Primary Care Companion for CNS Disorders|October 7, 2011
Late-onset cinephilia and compulsive behaviors: harbingers of frontotemporal dementiaAndrea Slachevsky, Carlos Muñoz-Neira, Javier Nuñez-Huasaf, et al.
Aging Clinical and Experimental Research|May 29, 2021
Norms and equivalences for MoCA-30, MoCA-22, and MMSE in the oldest-oldZarui A Melikyan, Michael Malek-Ahmadi, Kathleen O'Connor, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|October 7, 2005
Scopolamine reduces persistent activity related to long-term encoding in the parahippocampal gyrus during delayed matching in humansKarin Schon, Alireza Atri, Michael E Hasselmo, et al.
Pageof 15

Showing results (21-30 of 143) with videos related to

Sort By:
Pageof 15
Alzheimer Disease and Associated Disorders|June 27, 2008
Long-term course and effectiveness of combination therapy in Alzheimer diseaseAlireza Atri, Lynn W Shaughnessy, Joseph J Locascio, et al.
BMC Geriatrics|September 25, 2016
In the Information Age, do dementia caregivers get the information they need? Semi-structured interviews to determine informal caregivers' education needs, barriers, and preferencesKendra Peterson, Howard Hahn, Amber J Lee, et al.
Alzheimer'S Research & Therapy|May 11, 2021
Aducanumab produced a clinically meaningful benefit in association with amyloid loweringJeffrey Cummings, Paul Aisen, Cynthia Lemere, et al.
Alzheimer'S Research & Therapy|January 23, 2013
Memantine in patients with Alzheimer's disease receiving donepezil: new analyses of efficacy and safety for combination therapyAlireza Atri, José L Molinuevo, Ole Lemming, et al.
Journal of the International Neuropsychological Society : JINS|October 9, 2012
Neuropsychological test performance and cognitive reserve in healthy aging and the Alzheimer's disease spectrum: a theoretically driven factor analysisMeghan B Mitchell, Lynn W Shaughnessy, Steven D Shirk, et al.
Behavioral Neuroscience|June 14, 2003
Scopolamine impairs human recognition memory: data and modelingSeth J Sherman, Alireza Atri, Michael E Hasselmo, et al.
Brain : a Journal of Neurology|June 6, 2023
Amyloid-related imaging abnormalities (ARIA): radiological, biological and clinical characteristicsHarald Hampel, Aya Elhage, Min Cho, et al.
The Primary Care Companion for CNS Disorders|October 7, 2011
Late-onset cinephilia and compulsive behaviors: harbingers of frontotemporal dementiaAndrea Slachevsky, Carlos Muñoz-Neira, Javier Nuñez-Huasaf, et al.
Aging Clinical and Experimental Research|May 29, 2021
Norms and equivalences for MoCA-30, MoCA-22, and MMSE in the oldest-oldZarui A Melikyan, Michael Malek-Ahmadi, Kathleen O'Connor, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|October 7, 2005
Scopolamine reduces persistent activity related to long-term encoding in the parahippocampal gyrus during delayed matching in humansKarin Schon, Alireza Atri, Michael E Hasselmo, et al.
Pageof 15